Pregnancy recency and risk of ovarian cancer

Cancer Causes and Control

Volumn 10, Issue 5, 1999, Pages 397-402

  Cooper, Glinda S ^a   Schildkraut, Joellen M ^b   Whittemore, Alice S ^c   Marchbanks, Polly A ^c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

Epidemiology; Ovarian cancer; Pregnancy; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PREGNANCY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PREGNANCY; RISK FACTORS; TIME FACTORS;

EID: 0032831562     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008960520316     Document Type: Article

References (20)

1. Whittemore AS, Harris R, Itnyre J (1992) Collaborative Ovarian Cancer Group, Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case control studies. H. Invasive epithelial ovarian cancers in white women, Am J Epidemiol 136: 1184-1203.
2. Negri E, Franceschi S, Tzonou A, Booth M, La Vecchia C, Parazzini F, Beral V, Boyle P, Trichopoulos D (1991) Pooled analysis of 3 European case control studies: I: Reproductive factors and risk or epithelial ovarian cancer. Int J Cancer 49: 50-56.
3. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, Ekbom A, Janson PO (1994) Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344: 1250-1254.
4. Fathalla MF (1971) Incessant ovulation a factor in ovarian neoplasia? Lancet 2: 163.
5. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71: 717-721.
6. Whittemore AS, Harris R, Itnyre J (1992) Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol 136: 1212-1220.
7. Cooper GS (1995) Childbearing and risk of ovarian cancer. Lancet 345: 317-318.
8. Albrektsen G, Heuch I, Kvale G (1996) Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes Control 7: 421-427.
9. Whittemore AS, Harris R, Itnyre J, Halpern J (1992) Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case control studies, I. Methods. Am J Epidemiol 136: 1175-1183.
10. Casagrande JT, Pike MC, Ross, RK, Louie EW, Roy S, Henderson BE (1979) "Incessant ovulation" and ovarian cancer. Lancet 2: 170-173.
11. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ (1983) Determinants of ovarian cancer risk. I. Reproductive experiences and family history, J Natl Cancer Inst 71: 711-716.
12. The Cancer und Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. (1987) The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 316: 650-655.
13. Wu ML, Whittemore AS, Paffenbarger RS Jr. Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J (1988) Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 128: 1216-1227.
14. Godard B, Foulkes WK, Provencher D, Brunet JS, Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P (1998) Risk factors for familial and sporadic ovarian cancer among French Canadians: a case-control study. Am J Obset Gynecol 179: 403-410.
15. O'Leary P, Boyne P, Flett P, Beilby J, James I (1991) Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem 37: 667-672.
16. Rodriguez GC, Walmer D, Lessey B, Cline M, Krigman HR, Hughes CL (1998) The effect of contraceptive progestin on the ovarian epithelium: cancer prevention through apoptosis. J Soc Gynecol Invest 5: 271-276.
17. Bu SZ, Yin DL, Ren XH, Jiang LZ, Wu ZJ, Gao QR, Pei G (1997) Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 79: 1944-1950.
18. Chan LN, Zhang S, Cloyd M, Chan TS (1997) N-(4-hydroxyphenyl) retinamide prevents development of T-lymphomas in AKR/J mice. Anticancer Res 17: 499-503.
19. Inada T, Ichikawa A, Kubota T, Oguta Y, Moossa A, Hoffman RM (1997) 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res 17: 1965-1971.
20. Risio M, Lipkin M, Newmark H, Yang K, Rossini FP, Steele VE, Boone CW, Kelloff GJ (1996) Apoptosis, cell replication, and Western-style diet-induced tumorigenesis in mouse colon. Cancer Res 56: 4910-4916.